← All trials
NCT05272293
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2021
- Primary completion
- Dec 31, 2025
- Completion date
- Jun 30, 2026
- First posted
- Mar 9, 2022
- Last posted
- Mar 9, 2022
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyLead sponsor
- Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.